Prescription drugs are the company's fastest-growing segment, accounting for just over 16 percent of net sales during the quarter. According to CEO Björn Thorngren, a growing customer base is choosing to handle their prescription matters and pharmaceutical advice online.
The second quarter was another step on Meds' steady and long-term growth journey, Björn Thorngren states in the report.
Sales exceeded SEK 300 million in a single quarter for the first time. At the same time, EBIT increased by a full 38 percent. Meds continues to grow while proving our scalable business model.
Looking ahead to the second half of the year, the company's operational focus is on the establishment of a new logistics center in Eskilstuna. The new facility represents a tripling of the online pharmacy's warehouse space and is planned to be operational during the third quarter. Meds has signed an agreement with Arena Personal regarding the operation and staffing of the warehouse, a solution that the company believes is cost-neutral compared to their current logistics structure.
The move is expected to have a one-time impact of approximately SEK 25 million on sales and SEK 6 million on operating profit. The impact is primarily related to temporary capacity limitations and direct costs associated with the transition.
The priorities for the second half of the year are clear: continued profitable growth and successful establishment and start-up of the Eskilstuna logistics center, notes Björn Thorngren.
We are moving with existing machinery and processes, which reduces operational risk.